Follow the people · Insider
Blake Borgeson
Blake Borgeson files insider transactions with the SEC as a director of Recursion Pharmaceuticals (RXRX). We hold 9 disclosed purchases and sales filed since 19 April 2021, 3 of them in the last 90 days.
- Files forRXRX
- Disclosed buys and sells9 in all, 3 in the last 90 days
- Last disclosure2 September 2026
Positions held
1 post we hold — a term names its own dates; a run of filings only says when they filed- Filed 15 April 2021 — 1 September 2026Director · Recursion Pharmaceuticals (RXRX)104 Form 4 lines · source: SEC Form 4
Everything they disclosed
104 entries, newest first — one per disclosure report, one per Form 4 line- ▼ sold on the open market 30,000 shares of Recursion PharmaceuticalsSEC Form 42 September 2026Class A Common Stock · traded 1 September 2026 · filed 2 September 2026
- ▼ sold on the open market 30,000 shares of Recursion PharmaceuticalsSEC Form 46 August 2026Class A Common Stock · traded 4 August 2026 · filed 6 August 2026
- ▼ sold on the open market 40,000 shares of Recursion PharmaceuticalsSEC Form 49 July 2026Class A Common Stock · traded 7 July 2026 · filed 9 July 2026
- was granted 88,424 shares of Recursion PharmaceuticalsSEC Form 422 June 2026Class A Common Stock · traded 17 June 2026 · filed 22 June 2026
- ▼ sold on the open market 30,000 shares of Recursion PharmaceuticalsSEC Form 44 June 2026Class A Common Stock · traded 2 June 2026 · filed 4 June 2026
- ▼ sold on the open market 30,000 shares of Recursion PharmaceuticalsSEC Form 47 May 2026Class A Common Stock · traded 5 May 2026 · filed 7 May 2026
- ▼ sold on the open market 30,000 shares of Recursion PharmaceuticalsSEC Form 48 April 2026Class A Common Stock · traded 7 April 2026 · filed 8 April 2026
- ▼ sold on the open market 170,000 shares of Recursion PharmaceuticalsSEC Form 44 March 2026Class A Common Stock · traded 3 March 2026 · filed 4 March 2026
- ▼ sold on the open market 170,000 shares of Recursion PharmaceuticalsSEC Form 44 March 2026Class A Common Stock · traded 3 March 2026 · filed 4 March 2026
- ▼ sold on the open market 220,000 shares of Recursion PharmaceuticalsSEC Form 46 February 2026Class A Common Stock · traded 3 February 2026 · filed 6 February 2026
- ▼ sold on the open market 220,000 shares of Recursion PharmaceuticalsSEC Form 46 February 2026Class A Common Stock · traded 3 February 2026 · filed 6 February 2026
- ▼ sold on the open market 220,000 shares of Recursion PharmaceuticalsSEC Form 48 January 2026Class A Common Stock · traded 6 January 2026 · filed 8 January 2026
- ▼ sold on the open market 220,000 shares of Recursion PharmaceuticalsSEC Form 48 January 2026Class A Common Stock · traded 6 January 2026 · filed 8 January 2026
- ▼ sold on the open market 220,000 shares of Recursion PharmaceuticalsSEC Form 44 December 2025Class A Common Stock · traded 2 December 2025 · filed 4 December 2025
- was granted 44,031 shares of Recursion Pharmaceuticals (a derivative holding)SEC Form 423 June 2025Stock Option (Right to Buy) · traded 18 June 2025 · filed 23 June 2025
- was granted 22,016 shares of Recursion PharmaceuticalsSEC Form 423 June 2025Class A Common Stock · traded 18 June 2025 · filed 23 June 2025
- was granted 1,734 shares of Recursion PharmaceuticalsSEC Form 46 January 2025Class A Common Stock · traded 2 January 2025 · filed 6 January 2025
- ▼ sold on the open market 11,447 shares of Recursion PharmaceuticalsSEC Form 414 November 2024Class A Common Stock · traded 12 November 2024 · filed 14 November 2024
- ▼ sold on the open market 11,447 shares of Recursion PharmaceuticalsSEC Form 431 October 2024Class A Common Stock · traded 29 October 2024 · filed 31 October 2024
- ▼ sold on the open market 11,447 shares of Recursion PharmaceuticalsSEC Form 417 October 2024Class A Common Stock · traded 15 October 2024 · filed 17 October 2024
- was granted 2,026 shares of Recursion PharmaceuticalsSEC Form 44 October 2024Class A Common Stock · traded 1 October 2024 · filed 4 October 2024
- ▼ sold on the open market 11,447 shares of Recursion PharmaceuticalsSEC Form 43 October 2024Class A Common Stock · traded 1 October 2024 · filed 3 October 2024
- ▼ sold on the open market 11,447 shares of Recursion PharmaceuticalsSEC Form 419 September 2024Class A Common Stock · traded 17 September 2024 · filed 19 September 2024
- ▼ sold on the open market 11,447 shares of Recursion PharmaceuticalsSEC Form 45 September 2024Class A Common Stock · traded 3 September 2024 · filed 5 September 2024
- ▼ sold on the open market 11,447 shares of Recursion PharmaceuticalsSEC Form 422 August 2024Class A Common Stock · traded 20 August 2024 · filed 22 August 2024
- ▼ sold on the open market 11,447 shares of Recursion PharmaceuticalsSEC Form 48 August 2024Class A Common Stock · traded 6 August 2024 · filed 8 August 2024
- ▼ sold on the open market 11,447 shares of Recursion PharmaceuticalsSEC Form 425 July 2024Class A Common Stock · traded 23 July 2024 · filed 25 July 2024
- ▼ sold on the open market 11,447 shares of Recursion PharmaceuticalsSEC Form 411 July 2024Class A Common Stock · traded 9 July 2024 · filed 11 July 2024
- was granted 1,441 shares of Recursion PharmaceuticalsSEC Form 43 July 2024Class A Common Stock · traded 1 July 2024 · filed 3 July 2024
- ▼ sold on the open market 11,447 shares of Recursion PharmaceuticalsSEC Form 427 June 2024Class A Common Stock · traded 25 June 2024 · filed 27 June 2024
- ▼ sold on the open market 11,447 shares of Recursion PharmaceuticalsSEC Form 413 June 2024Class A Common Stock · traded 11 June 2024 · filed 13 June 2024
- was granted 26,193 shares of Recursion Pharmaceuticals (a derivative holding)SEC Form 45 June 2024Stock Option (Right to Buy) · traded 3 June 2024 · filed 5 June 2024
- was granted 13,097 shares of Recursion PharmaceuticalsSEC Form 45 June 2024Class A Common Stock · traded 3 June 2024 · filed 5 June 2024
- ▼ sold on the open market 11,447 shares of Recursion PharmaceuticalsSEC Form 430 May 2024Class A Common Stock · traded 28 May 2024 · filed 30 May 2024
- ▼ sold on the open market 20,054 shares of Recursion PharmaceuticalsSEC Form 416 May 2024Class A Common Stock · traded 14 May 2024 · filed 16 May 2024
- ▼ sold on the open market 11,447 shares of Recursion PharmaceuticalsSEC Form 42 May 2024Class A Common Stock · traded 30 April 2024 · filed 2 May 2024
- ▼ sold on the open market 11,447 shares of Recursion PharmaceuticalsSEC Form 418 April 2024Class A Common Stock · traded 16 April 2024 · filed 18 April 2024
- ▼ sold on the open market 11,447 shares of Recursion PharmaceuticalsSEC Form 43 April 2024Class A Common Stock · traded 2 April 2024 · filed 3 April 2024
- ▼ sold on the open market 20,054 shares of Recursion PharmaceuticalsSEC Form 421 March 2024Class A Common Stock · traded 19 March 2024 · filed 21 March 2024
- ▼ sold on the open market 20,054 shares of Recursion PharmaceuticalsSEC Form 47 March 2024Class A Common Stock · traded 5 March 2024 · filed 7 March 2024
- ▼ sold on the open market 19,745 shares of Recursion PharmaceuticalsSEC Form 421 February 2024Class A Common Stock · traded 20 February 2024 · filed 21 February 2024
- ▼ sold on the open market 309 shares of Recursion PharmaceuticalsSEC Form 421 February 2024Class A Common Stock · traded 20 February 2024 · filed 21 February 2024
- ▼ sold on the open market 11,447 shares of Recursion PharmaceuticalsSEC Form 48 February 2024Class A Common Stock · traded 6 February 2024 · filed 8 February 2024
- ▼ sold on the open market 20,054 shares of Recursion PharmaceuticalsSEC Form 425 January 2024Class A Common Stock · traded 23 January 2024 · filed 25 January 2024
- ▼ sold on the open market 6,303 shares of Recursion PharmaceuticalsSEC Form 411 January 2024Class A Common Stock · traded 9 January 2024 · filed 11 January 2024
- ▼ sold on the open market 13,751 shares of Recursion PharmaceuticalsSEC Form 411 January 2024Class A Common Stock · traded 9 January 2024 · filed 11 January 2024
- ▼ sold on the open market 20,054 shares of Recursion PharmaceuticalsSEC Form 428 December 2023Class A Common Stock · traded 26 December 2023 · filed 28 December 2023
- ▼ sold on the open market 11,447 shares of Recursion PharmaceuticalsSEC Form 414 December 2023Class A Common Stock · traded 12 December 2023 · filed 14 December 2023
- ▼ sold on the open market 11,447 shares of Recursion PharmaceuticalsSEC Form 430 November 2023Class A Common Stock · traded 28 November 2023 · filed 30 November 2023
- ▼ sold on the open market 8,885 shares of Recursion PharmaceuticalsSEC Form 416 November 2023Class A Common Stock · traded 14 November 2023 · filed 16 November 2023
- ▼ sold on the open market 8,885 shares of Recursion PharmaceuticalsSEC Form 42 November 2023Class A Common Stock · traded 31 October 2023 · filed 2 November 2023
- ▼ sold on the open market 8,885 shares of Recursion PharmaceuticalsSEC Form 419 October 2023Class A Common Stock · traded 17 October 2023 · filed 19 October 2023
- ▼ sold on the open market 8,885 shares of Recursion PharmaceuticalsSEC Form 45 October 2023Class A Common Stock · traded 3 October 2023 · filed 5 October 2023
- ▼ sold on the open market 8,885 shares of Recursion PharmaceuticalsSEC Form 421 September 2023Class A Common Stock · traded 19 September 2023 · filed 21 September 2023
- ▼ sold on the open market 8,885 shares of Recursion PharmaceuticalsSEC Form 47 September 2023Class A Common Stock · traded 5 September 2023 · filed 7 September 2023
- ▼ sold on the open market 8,885 shares of Recursion PharmaceuticalsSEC Form 424 August 2023Class A Common Stock · traded 22 August 2023 · filed 24 August 2023
- ▼ sold on the open market 14,498 shares of Recursion PharmaceuticalsSEC Form 410 August 2023Class A Common Stock · traded 8 August 2023 · filed 10 August 2023
- ▼ sold on the open market 3,272 shares of Recursion PharmaceuticalsSEC Form 410 August 2023Class A Common Stock · traded 8 August 2023 · filed 10 August 2023
- gave away 14,000 shares of Recursion PharmaceuticalsSEC Form 427 July 2023Class A Common Stock · traded 29 June 2023 · filed 27 July 2023
- ▼ sold on the open market 18,719 shares of Recursion PharmaceuticalsSEC Form 427 July 2023Class A Common Stock · traded 25 July 2023 · filed 27 July 2023
- ▼ sold on the open market 8,885 shares of Recursion PharmaceuticalsSEC Form 413 July 2023Class A Common Stock · traded 11 July 2023 · filed 13 July 2023
- ▼ sold on the open market 8,885 shares of Recursion PharmaceuticalsSEC Form 429 June 2023Class A Common Stock · traded 27 June 2023 · filed 29 June 2023
- was granted 25,224 shares of Recursion Pharmaceuticals (a derivative holding)SEC Form 421 June 2023Stock Option (Right to Buy · traded 16 June 2023 · filed 21 June 2023
- was granted 12,612 shares of Recursion PharmaceuticalsSEC Form 421 June 2023Class A Common Stock · traded 16 June 2023 · filed 21 June 2023
- ▼ sold on the open market 15,485 shares of Recursion PharmaceuticalsSEC Form 415 June 2023Class A Common Stock · traded 13 June 2023 · filed 15 June 2023
- ▼ sold on the open market 8,885 shares of Recursion PharmaceuticalsSEC Form 41 June 2023Class A Common Stock · traded 30 May 2023 · filed 1 June 2023
- ▼ sold on the open market 8,885 shares of Recursion PharmaceuticalsSEC Form 417 May 2023Class A Common Stock · traded 16 May 2023 · filed 17 May 2023
- ▼ sold on the open market 8,885 shares of Recursion PharmaceuticalsSEC Form 420 April 2023Class A Common Stock · traded 18 April 2023 · filed 20 April 2023
- ▼ sold on the open market 8,885 shares of Recursion PharmaceuticalsSEC Form 46 April 2023Class A Common Stock · traded 4 April 2023 · filed 6 April 2023
- ▼ sold on the open market 8,885 shares of Recursion PharmaceuticalsSEC Form 423 March 2023Class A Common Stock · traded 21 March 2023 · filed 23 March 2023
- ▼ sold on the open market 8,885 shares of Recursion PharmaceuticalsSEC Form 49 March 2023Class A Common Stock · traded 7 March 2023 · filed 9 March 2023
- ▼ sold on the open market 8,885 shares of Recursion PharmaceuticalsSEC Form 423 February 2023Class A Common Stock · traded 21 February 2023 · filed 23 February 2023
- ▼ sold on the open market 8,885 shares of Recursion PharmaceuticalsSEC Form 49 February 2023Class A Common Stock · traded 7 February 2023 · filed 9 February 2023
- ▼ sold on the open market 8,885 shares of Recursion PharmaceuticalsSEC Form 426 January 2023Class A Common Stock · traded 24 January 2023 · filed 26 January 2023
- ▼ sold on the open market 8,885 shares of Recursion PharmaceuticalsSEC Form 412 January 2023Class A Common Stock · traded 10 January 2023 · filed 12 January 2023
- was granted 1,325 shares of Recursion PharmaceuticalsSEC Form 45 January 2023Class A Common Stock · traded 3 January 2023 · filed 5 January 2023
- ▼ sold on the open market 8,885 shares of Recursion PharmaceuticalsSEC Form 429 December 2022Class A Common Stock · traded 27 December 2022 · filed 29 December 2022
- ▼ sold on the open market 8,885 shares of Recursion PharmaceuticalsSEC Form 415 December 2022Class A Common Stock · traded 13 December 2022 · filed 15 December 2022
- ▼ sold on the open market 8,885 shares of Recursion PharmaceuticalsSEC Form 41 December 2022Class A Common Stock · traded 29 November 2022 · filed 1 December 2022
- ▼ sold on the open market 17,770 shares of Recursion PharmaceuticalsSEC Form 418 November 2022Class A Common Stock · traded 16 November 2022 · filed 18 November 2022
- was granted 920 shares of RXRXSEC Form 45 October 2022Class A Common Stock · traded 3 October 2022 · filed 5 October 2022
- was granted 1,186 shares of Recursion PharmaceuticalsSEC Form 46 July 2022Class A Common Stock · traded 1 July 2022 · filed 6 July 2022
- was granted 36,290 shares of Recursion Pharmaceuticals (a derivative holding)SEC Form 416 June 2022Stock Option (right to buy) · traded 14 June 2022 · filed 16 June 2022
- was granted 18,145 shares of Recursion PharmaceuticalsSEC Form 416 June 2022Class A Common Stock · traded 14 June 2022 · filed 16 June 2022
- was granted 1,300 shares of Recursion PharmaceuticalsSEC Form 45 April 2022Class A Common Stock · traded 1 April 2022 · filed 5 April 2022
- was granted 555 shares of Recursion PharmaceuticalsSEC Form 45 January 2022Class A Common Stock · traded 3 January 2022 · filed 5 January 2022
- ▼ sold on the open market 9,625 shares of Recursion PharmaceuticalsSEC Form 45 January 2022Class A Common Stock · traded 4 January 2022 · filed 5 January 2022
- ▼ sold on the open market 9,625 shares of Recursion PharmaceuticalsSEC Form 423 December 2021Class A Common Stock · traded 21 December 2021 · filed 23 December 2021
- ▼ sold on the open market 1,500 shares of Recursion PharmaceuticalsSEC Form 49 December 2021Class A Common Stock · traded 7 December 2021 · filed 9 December 2021
- ▼ sold on the open market 7,725 shares of Recursion PharmaceuticalsSEC Form 49 December 2021Class A Common Stock · traded 7 December 2021 · filed 9 December 2021
- ▼ sold on the open market 400 shares of Recursion PharmaceuticalsSEC Form 49 December 2021Class A Common Stock · traded 7 December 2021 · filed 9 December 2021
- ▼ sold on the open market 1,900 shares of Recursion PharmaceuticalsSEC Form 422 November 2021Class A Common Stock · traded 18 November 2021 · filed 22 November 2021
- ▼ sold on the open market 7,725 shares of Recursion PharmaceuticalsSEC Form 422 November 2021Class A Common Stock · traded 18 November 2021 · filed 22 November 2021
- was granted 457 shares of Recursion PharmaceuticalsSEC Form 45 October 2021Class A Common Stock · traded 1 October 2021 · filed 5 October 2021
- was granted 278 shares of Recursion PharmaceuticalsSEC Form 46 July 2021Class A Common Stock · traded 1 July 2021 · filed 6 July 2021
- converted 923,052 shares of Recursion PharmaceuticalsSEC Form 422 April 2021Common Stock · traded 20 April 2021 · filed 22 April 2021
- converted 7,688,356 shares of Recursion PharmaceuticalsSEC Form 422 April 2021Common Stock · traded 20 April 2021 · filed 22 April 2021
- converted 7,688,356 shares of Recursion PharmaceuticalsSEC Form 422 April 2021Class A Common Stock · traded 20 April 2021 · filed 22 April 2021
- converted 378,309 shares of Recursion Pharmaceuticals (a derivative holding)SEC Form 422 April 2021Series A Preferred Stock · traded 20 April 2021 · filed 22 April 2021
- converted 544,743 shares of Recursion Pharmaceuticals (a derivative holding)SEC Form 422 April 2021Series A-1 Preferred Stock · traded 20 April 2021 · filed 22 April 2021
- converted 12,500 shares of Recursion Pharmaceuticals (a derivative holding)SEC Form 422 April 2021Stock Option (Right to Buy) · traded 20 April 2021 · filed 22 April 2021
- converted 12,500 shares of Recursion Pharmaceuticals (a derivative holding)SEC Form 422 April 2021Stock Option (Right to Buy) · traded 20 April 2021 · filed 22 April 2021
- was granted 12,500 shares of Recursion Pharmaceuticals (a derivative holding)SEC Form 419 April 2021Stock Option (Right to Buy) · traded 15 April 2021 · filed 19 April 2021
- was granted 6,250 shares of Recursion PharmaceuticalsSEC Form 419 April 2021Common Stock · traded 16 April 2021 · filed 19 April 2021
Positions come from the unitedstates/congress-legislators roster, the Office of Government Ethics and the SEC’s Form 4 index. Every disclosed line names its own source and links the document the government published; we print what the filing says and never a price we did not read from it. Headlines and links come from the GDELT Global Knowledge Graph — the story stays with the publisher. The portrait, where we have one, is the public-domain Congressional Bioguide photograph.